Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of tau protein in Alzheimer's disease: The prime pathological player
Shibi Muralidar, Senthil Visaga Ambi, Saravanan Sekaran, et al.
International Journal of Biological Macromolecules (2020) Vol. 163, pp. 1599-1617
Closed Access | Times Cited: 170

Showing 1-25 of 170 citing articles:

Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
Priyanka Rawat, Ujala Sehar, Jasbir Bisht, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12841-12841
Open Access | Times Cited: 160
Neuropathogenesis-on-chips for neurodegenerative diseases
Sarnai Amartumur, Huong Mai Nguyen, Thuy Huynh, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 20
Heavy metals: toxicity and human health effects
Klaudia Jomová, Suliman Yousef Alomar, Eugenie Nepovimová, et al.
Archives of Toxicology (2024)
Open Access | Times Cited: 15
Protection against Alzheimer's disease by luteolin: Role of brain glucose regulation, anti‐inflammatory activity, and the gut microbiota‐liver‐brain axis
James W. Daily, Suna Kang, Sunmin Park
BioFactors (2020) Vol. 47, Iss. 2, pp. 218-231
Closed Access | Times Cited: 107
Role of Nrf2 in Synaptic Plasticity and Memory in Alzheimer’s Disease
Don A. Davies, Aida Adlimoghaddam, Benedict C. Albensi
Cells (2021) Vol. 10, Iss. 8, pp. 1884-1884
Open Access | Times Cited: 66
Nanomaterials toward the treatment of Alzheimer’s disease: Recent advances and future trends
Huihui Zeng, Yujie Qi, Zheyu Zhang, et al.
Chinese Chemical Letters (2021) Vol. 32, Iss. 6, pp. 1857-1868
Closed Access | Times Cited: 59
Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer’s Disease and Identifying Promising Drug Targets
Zdeněk Fišar
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1676-1676
Open Access | Times Cited: 51
Roles of ApoE4 on the Pathogenesis in Alzheimer’s Disease and the Potential Therapeutic Approaches
Yu-Ying Sun, Zhun Wang, Han‐Chang Huang
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 7, pp. 3115-3136
Open Access | Times Cited: 37
Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies
Kendall B. E. Moore, Ta-Jung Hung, Jessica S. Fortin
Drug Discovery Today (2023) Vol. 28, Iss. 3, pp. 103487-103487
Open Access | Times Cited: 36
CNS Border-Associated Macrophages: Ontogeny and Potential Implication in Disease
Iasonas Dermitzakis, Paschalis Theotokis, Paschalis Evangelidis, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 5, pp. 4285-4300
Open Access | Times Cited: 28
Exploring the role of COX-2 in Alzheimer's disease: Potential therapeutic implications of COX-2 inhibitors
Nathalie Moussa, Ninar Dayoub
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 9, pp. 101729-101729
Open Access | Times Cited: 27
Natural Alkaloids as Multi-Target Compounds towards Factors Implicated in Alzheimer’s Disease
Rudolf Vrabec, Gerald Blunden, Lucie Cahlíková
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4399-4399
Open Access | Times Cited: 23
Alzheimer's disease: The role of proteins in formation, mechanisms, and new therapeutic approaches
Amirreza Gholami
Neuroscience Letters (2023) Vol. 817, pp. 137532-137532
Closed Access | Times Cited: 21
Treating Alzheimer’s disease using nanoparticle-mediated drug delivery strategies/systems
Aryan Kia Roghani, Ricardo Isaiah Garcia, Ali Roghani, et al.
Ageing Research Reviews (2024) Vol. 97, pp. 102291-102291
Closed Access | Times Cited: 10
Design, Synthesis, and Biological Investigation of Quinazoline Derivatives as Multitargeting Therapeutics in Alzheimer’s Disease Therapy
Akash Verma, Digambar Kumar Waiker, Neha Singh, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 4, pp. 745-771
Closed Access | Times Cited: 8
Agmatine as a novel intervention for Alzheimer's disease: Pathological insights and cognitive benefits
Raj Katariya, Shivkumar S. Sammeta, Mayur B. Kale, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102269-102269
Closed Access | Times Cited: 7
Navigating the Maze of Alzheimer’s disease by exploring BACE1: Discovery, current scenario, and future prospects
Faiza Iram, Mohammad Shahid, Jaoud Ansari, et al.
Ageing Research Reviews (2024) Vol. 98, pp. 102342-102342
Closed Access | Times Cited: 7
Overview of therapeutic targets in management of dementia
Rohit Malik, Sunishtha Kalra, Saurabh Bhatia, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 152, pp. 113168-113168
Open Access | Times Cited: 30
The Interaction Between NF-κB and Estrogen in Alzheimer’s Disease
Pranav Mishra, Don A. Davies, Benedict C. Albensi
Molecular Neurobiology (2022) Vol. 60, Iss. 3, pp. 1515-1526
Closed Access | Times Cited: 27
The role of glycogen synthase kinase 3 beta in neurodegenerative diseases
Honglu Yu, Min Xiong, Zhentao Zhang
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 19
Impact of Microbiome–Brain Communication on Neuroinflammation and Neurodegeneration
Iris Stolzer, E Scherer, Patrick Süß, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14925-14925
Open Access | Times Cited: 17
Nanotechnology-based gene therapy as a credible tool in the treatment of Alzheimer’s disease
NigelH Greig, Aziz Unnisa, MohammadAmjad Kamal
Neural Regeneration Research (2023) Vol. 18, Iss. 10, pp. 2127-2127
Open Access | Times Cited: 15
Pathophysiological Aspects and Therapeutic Armamentarium of Alzheimer’s Disease: Recent Trends and Future Development
Bhavarth P. Dave, Yesha Shah, Kunal G. Maheshwari, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 8, pp. 3847-3884
Closed Access | Times Cited: 15
Reelin links Apolipoprotein E4, Tau, and Amyloid‐β in Alzheimer’s disease
Ling Yi, Li Zeng, Qing Wang, et al.
Ageing Research Reviews (2024) Vol. 98, pp. 102339-102339
Closed Access | Times Cited: 6
Recent Advances in Targeting Transition Metals (Copper, Iron, and Zinc) in Alzheimer’s Disease
Raghuraj Singh, Archna Panghal, Krishna Jadhav, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 12, pp. 10916-10940
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top